- conflicts or gaps
- [[{"field": "founders", "conflict": "YC lists 2 founders (Aaron Lazarus, Omeed Rahimi); FounderTrace and LinkedIn also identify Bradley M. Keegan as co-founder", "source_urls": ["https://www.ycombinator.com/companies/encepheal-therapeutics", "https://foundertrace.com/companies/encepheal_therapeutics/", "https://linkedin.com/in/bradleymichaelkeegan"]}, {"field": "employees", "conflict": "Headcount reported as 3 (YC), 5 (YCDB), 5-9 (InKnowvation), 2-10 (BounceWatch)", "source_urls": ["https://www.ycombinator.com/companies/encepheal-therapeutics", "https://www.ycdb.co/company/encepheal-therapeutics", "https://www.inknowvation.com/sbir/companies/encepheal-therapeutics-inc", "https://bouncewatch.com/company/encepheal-therapeutics"]}, {"field": "funding.total_equity_debt", "conflict": "BounceWatch reports $300K total equity/debt; LinkedIn company snippet reports $425K total funding across 2 rounds", "source_urls": ["https://bouncewatch.com/company/encepheal-therapeutics", "https://linkedin.com/in/aaron-lazarus-b106b04a"]}, {"field": "funding.nc_biotech_early_loan_date", "conflict": "NCBiotech article confirms $150K early loan but not award date; secondary sources cite 2017 without primary award record retrieved", "source_urls": ["https://www.ncbiotech.org/news/ncs-encepheal-lands-nih-grant-treat-cocaine-addiction"]}, {"field": "exit_status.acquisition", "conflict": "PrivCo lists 2024-03-15 completed M&A; YC lists Inactive with no exit; no independent confirmation found", "source_urls": ["https://www.privco.com/company/encepheal-therapeutics", "https://www.ycombinator.com/companies/encepheal-therapeutics"]}, {"field": "website", "conflict": "Historical website http://www.encepheal.com referenced by YC/NCBiotech; domain currently hosts unrelated content", "source_urls": ["https://yc-oss.github.io/api/batches/summer-2019/encepheal-therapeutics.json", "http://www.encepheal.com"]}, {"field": "products.ip", "conflict": "Federal Register NIH exclusive patent license notice (2017) not accessible programmatically; company patent holdings listed N/A on InKnowvation", "source_urls": ["https://www.federalregister.gov/documents/2017/10/02/2017-21048/prospective-modification-of-exclusive-patent-license-potent-and-selective-analogues-of-monamine", "https://www.inknowvation.com/sbir/companies/encepheal-therapeutics-inc"]}, {"field": "exit_status.shutdown_date", "conflict": "No official dissolution filing or shutdown announcement found; CEO tenure ended Mar 2022; YC status Inactive with no date", "source_urls": ["https://linkedin.com/in/aaron-lazarus-b106b04a", "https://www.ycombinator.com/companies/encepheal-therapeutics"]}, {"field": "spelling", "conflict": "Company name spelled Encepheal, EncepHeal, and EncepHeal interchangeably across official sources", "source_urls": ["https://www.ycombinator.com/companies/encepheal-therapeutics", "https://www.ncbiotech.org/news/ncs-encepheal-lands-nih-grant-treat-cocaine-addiction", "https://www.inknowvation.com/sbir/companies/encepheal-therapeutics-inc"]}]]
- source urls
- ["http://www.encepheal.com", "https://bouncewatch.com/company/encepheal-therapeutics", "https://foundertrace.com/companies/encepheal_therapeutics/", "https://linkedin.com/in/aaron-lazarus-b106b04a", "https://linkedin.com/in/bradleymichaelkeegan", "https://www.federalregister.gov/documents/2017/10/02/2017-21048/prospective-modification-of-exclusive-patent-license-potent-and-selective-analogues-of-monamine", "https://www.inknowvation.com/sbir/companies/encepheal-therapeutics-inc", "https://www.ncbiotech.org/funding/company-funding/small-business-research-loan", "https://www.ncbiotech.org/news/ncs-encepheal-lands-nih-grant-treat-cocaine-addiction", "https://www.ncbiotech.org/news/ncs-encepheal-lands-nih-grant-treat-cocaine-adiction", "https://www.privco.com/company/encepheal-therapeutics", "https://www.ycdb.co/company/encepheal-therapeutics", "https://www.ycombinator.com/blog/new-standard-deal", "https://www.ycombinator.com/companies/encepheal-therapeutics", "https://yc-oss.github.io/api/batches/summer-2019/encepheal-therapeutics.json"]